Skip to main content
. 2022 Aug 9;127(8):1497–1506. doi: 10.1038/s41416-022-01941-0

Fig. 4. Overall survival for AFHX-treated patients.

Fig. 4

Twenty-eight patients proceeded to treatment with chemo-re-irradiation with AFHX following re-induction per protocol. The estimated 60-month overall survival was 44% (95% CI: 24–62%).